LAURA BONDS, MD
Neurology Physician in SHENANDOAH, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LAURA BONDS, MD reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 1,253 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 1K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LAURA BONDS, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
LAURA BONDS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about LAURA BONDS, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Neurology Physician compares to other specialties among Texas providers
Neurology Physician share within Texas
Neurology Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
LAURA BONDS, MD's 2023 MIPS final score plotted against the Neurology Physician national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neurology Physician) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Neurology Physician US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Neurology Physician. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LAURA BONDS, MD appears in the CMS NPPES registry as a Neurology Physician provider holding MD credentials at 129 VISION PARK BLVD STE 201, SHENANDOAH, TX, 77384, with a listed phone of (369) 267-0912. NPI 1295919116 was issued on 12/27/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BONDS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,253 prescription claims written by this provider, covering 167 Medicare beneficiaries and totaling roughly $274K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1295919116 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 12/27/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LAURA BONDS, MD's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LAURA BONDS, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.3K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to LAURA BONDS, MD. To verify LAURA BONDS, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 1,253 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,708
- Total Day Supply
- 79,340
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $234K
- Generic Drug Cost
- $40K
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.27
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 12, 65-74: 85, 75-84: 58, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LAURA BONDS, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Duloxetine Hcl
Duloxetine Hcl
114 claims
- Sumatriptan Succin…
Sumatriptan Succinate
108 claims
- Venlafaxine Hcl Er
Venlafaxine Hcl Er
87 claims
- Gabapentin
Gabapentin
69 claims
- Memantine Hcl
Memantine Hcl
66 claims
- Aimovig Autoinjector
Aimovig Autoinjector
59 claims
- Donepezil Hcl
Donepezil Hcl
55 claims
- Rizatriptan
Rizatriptan
53 claims
| Drug | Claims |
|---|---|
| Duloxetine Hcl | 114 |
| Sumatriptan Succinate | 108 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 87 |
| Gabapentin | 69 |
| Memantine Hcl | 66 |
| Aimovig Autoinjector Erenumab-Aooe | 59 |
| Donepezil Hcl | 55 |
| Rizatriptan Rizatriptan Benzoate | 53 |
| Botox Onabotulinumtoxina | 50 |
| Topiramate | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How LAURA BONDS, MD fits within the Neurology Physician landscape nationally.
LAURA BONDS, MD's 1,253 claims are below the specialty average of 1,309.
Nearby Neurology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BONDS.
Compare Neurology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is LAURA BONDS, MD's specialty? ▼
How much does LAURA BONDS, MD prescribe under Medicare Part D? ▼
What is LAURA BONDS, MD's Medicare quality score? ▼
Where is LAURA BONDS, MD located? ▼
What is LAURA BONDS, MD's NPI number? ▼
Does LAURA BONDS, MD prescribe more brand-name or generic drugs? ▼
How many Neurology Physician providers are there in the US? ▼
What drugs does LAURA BONDS, MD prescribe most often? ▼
Does LAURA BONDS, MD accept Medicare? ▼
How can I verify LAURA BONDS, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology